Mature Reproductive Age

Mature reproductive age is a clinical designation for women aged 35 and older who are attempting pregnancy, acknowledging that fertility potential, egg quality, and time-to-pregnancy change meaningfully as the ovarian reserve that was built across childhood declines with accelerating pace through the mid-thirties and beyond. The designation does not imply a fertility cliff. It signals that a couple presenting at this stage benefits from greater clinical urgency and diagnostic depth.

The biological changes are real and measurable. Oocyte aneuploidy rates rise with age, extending time-to-pregnancy and increasing early pregnancy loss. AMH and antral follicle count both decline, reflecting the shrinking ovarian follicle pool. Cycle regularity may remain intact while egg quality and fertilization potential fall. These changes confront every clinician working with older reproductive-age couples, regardless of the care model.1

Restorative care produces meaningful outcomes in this population. A 2025 single-center cohort study of 1,310 infertile couples treated with NaProTechnology, in which the mean age of women was 35.0 years (SD 4.4), reported an adjusted cumulative take-home baby rate of 62.1%. Age-stratified rates were 53.3% for women aged 36 to 40 and 24.4% for women over 40.14,93 These results came from a population with unfavorable prognostic factors, including prolonged infertility duration and prior ART attempts in more than a quarter of couples. Both partners receive evaluation from the outset; male factor is solely responsible in approximately 20% of infertile couples and contributes in an additional 30 to 40%.3

Cited in this entry

  1. Steiner AZ et al. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA. 2017. JAMA. https://rrmacademy.org/library/association-between-biomarkers-of-ovarian-reserve-and-infertility-among-older-wo-reckxs7k83ltnbrhv/
  2. NaProTechnology for infertility: take-home baby rate and clinical outcomes in a 5-year single-center cohort. PubMed. https://pubmed.ncbi.nlm.nih.gov/41323405/
  3. Schlegel PN, Sigman M, Collura B, et al. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I. Fertil Steril. 2021;115(1):54-61. Fertility and Sterility. https://pubmed.ncbi.nlm.nih.gov/33295257/

Discussed in

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.